Megan Wenger

722 total citations
15 papers, 363 citations indexed

About

Megan Wenger is a scholar working on Oncology, Pathology and Forensic Medicine and Infectious Diseases. According to data from OpenAlex, Megan Wenger has authored 15 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 4 papers in Infectious Diseases. Recurrent topics in Megan Wenger's work include Viral-associated cancers and disorders (11 papers), Lymphoma Diagnosis and Treatment (7 papers) and HIV/AIDS Research and Interventions (3 papers). Megan Wenger is often cited by papers focused on Viral-associated cancers and disorders (11 papers), Lymphoma Diagnosis and Treatment (7 papers) and HIV/AIDS Research and Interventions (3 papers). Megan Wenger collaborates with scholars based in United States, Uganda and Kenya. Megan Wenger's co-authors include Mwebesa Bwana, Kara Wools‐Kaloustian, Andrew Kambugu, Constantin T. Yiannoutsos, Jeffrey N. Martin, Elvin Geng, David V. Glidden, Lameck Diero, Rita Lyamuya and Paula Braitstein and has published in prestigious journals such as Clinical Infectious Diseases, Science Advances and BMC Cancer.

In The Last Decade

Megan Wenger

14 papers receiving 362 citations

Peers

Countries citing papers authored by Megan Wenger

Since Specialization

Citations

This map shows the geographic impact of Megan Wenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Wenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Wenger more than expected).

Fields of papers citing papers by Megan Wenger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan Wenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Wenger. The network helps show where Megan Wenger may publish in the future.

Co-authorship network of co-authors of Megan Wenger

This figure shows the co-authorship network connecting the top 25 collaborators of Megan Wenger. A scholar is included among the top collaborators of Megan Wenger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan Wenger. Megan Wenger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Survival After Diagnosis of HIV-Associated Kaposi Sarcoma Among Adults in East Africa in the “Treat-All” Era 2025 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Helen Byakwaga, Aggrey Semeere, (unknown), Naftali Busakhala, Esther E. Freeman, (unknown), Megan Wenger, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Toby Maurer, David V. Glidden, Kara Wools‐Kaloustian, Andrew Kambugu, Jeffrey N. Martin	0
2	LAMP-enabled diagnosis of Kaposi’s sarcoma for sub-Saharan Africa 2023 ·Science Advances ·(unknown), Aggrey Semeere, (unknown), (unknown), Robert Lukande, (unknown), (unknown), Megan Wenger, Philip E. LeBoit, (unknown), Toby Maurer, (unknown), (unknown), Ethel Cesarman, Jeffrey N. Martin, David Erickson	4
3	Beyond T Staging in the “Treat-All” Era: Severity and Heterogeneity of Kaposi Sarcoma in East Africa 2021 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Esther E. Freeman, Aggrey Semeere, Devon E. McMahon, Helen Byakwaga, (unknown), Susan Regan, Megan Wenger, (unknown), (unknown), Mwebesa Bwana, (unknown), (unknown), (unknown), (unknown), Kara Wools‐Kaloustian, Ingrid V. Bassett, Naftali Busakhala, Jeffrey N. Martin	11
4	Feasibility of Rapid Case Ascertainment for Cancer in East Africa: An Investigation of Community-Representative Kaposi Sarcoma in the Era of Antiretroviral Therapy 2021 ·Cancer Epidemiology ·Aggrey Semeere, Helen Byakwaga, (unknown), Esther E. Freeman, Naftali Busakhala, Megan Wenger, (unknown), (unknown), Mwebesa Bwana, (unknown), (unknown), (unknown), (unknown), Edwin Sang, Toby Maurer, Kara Wools‐Kaloustian, Andrew Kambugu, Jeffrey N. Martin	4
5	Using Media to Promote Public Awareness of Early Detection of Kaposi’s Sarcoma in Africa 2020 ·Journal of Oncology ·(unknown), Lisa Butler, (unknown), Robert Inglis, Megan Wenger, Edward Katongole‐Mbidde, Toby Maurer, Andrew Kambugu, Jeffrey N. Martin	1
6	Real-world use of chemotherapy for Kaposi’s sarcoma in a large community-based HIV primary care system in Kenya 2020 ·BMC Cancer ·Esther E. Freeman, Naftali Busakhala, Susan Regan, Fredrick Chite Asirwa, Megan Wenger, Divya Seth, (unknown), Aggrey Semeere, Toby Maurer, Kara Wools‐Kaloustian, Ingrid V. Bassett, Jeffrey N. Martin	10
7	A prospective ascertainment of cancer incidence in sub‐Saharan Africa: The case of Kaposi sarcoma 2016 ·Cancer Medicine ·Aggrey Semeere, Megan Wenger, Naftali Busakhala, Nathan Buziba, Mwebesa Bwana, Winnie Muyindike, Erin Amerson, Toby Maurer, Timothy H. McCalmont, Philip E. LeBoit, Beverly Musick, Constantin T. Yiannoutsos, Robert Lukande, Barbara Castelnuovo, (unknown), Andrew Kambugu, David V. Glidden, Kara Wools‐Kaloustian, Jeffrey N. Martin	33
8	Implementation and Operational Research: Use of Symptom Screening and Sputum Microscopy Testing for Active Tuberculosis Case Detection Among HIV-Infected Patients in Real-World Clinical Practice in Uganda 2016 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Monika Roy, Winnie Muyindike, Tara Vijayan, (unknown), Mwebesa Bwana, Megan Wenger, Jeffrey N. Martin, Elvin Geng	9
9	Task Shifting and Skin Punch for the Histologic Diagnosis of Kaposi's Sarcoma in Sub-Saharan Africa: A Public Health Solution to a Public Health Problem 2015 ·Oncology ·(unknown), Megan Wenger, Aggrey Semeere, Barbara Castelnuovo, Andrew Kambugu, Robert Lukande, Fredrick Chite Asirwa, Naftali Busakhala, Nathan Buziba, Lameck Diero, Kara Wools‐Kaloustian, Robert Matthew Strother, Mwebesa Bwana, Winnie Muyindike, Erin Amerson, Edward Mbidde, Toby Maurer, Jeffrey N. Martin	25
10	Retention in Care and Patient-Reported Reasons for Undocumented Transfer or Stopping Care Among HIV-Infected Patients on Antiretroviral Therapy in Eastern Africa: Application of a Sampling-Based Approach 2015 ·Clinical Infectious Diseases ·Elvin Geng, Thomas Odeny, Rita Lyamuya, (unknown), Lameck Diero, Mwebesa Bwana, Paula Braitstein, Geoffrey Somi, Andrew Kambugu, Elizabeth A. Bukusi, Megan Wenger, Torsten B. Neilands, David V. Glidden, Kara Wools‐Kaloustian, Constantin T. Yiannoutsos, Jeffrey N. Martin	131
11	Accuracy of Clinical Suspicion and Pathologic Diagnosis of Kaposi Sarcoma in East Africa 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Erin Amerson, (unknown), Amy Forrestel, Megan Wenger, Timothy H. McCalmont, Philip E. LeBoit, Toby Maurer, (unknown), Winnie Muyindike, Mwebesa Bwana, Nathan Buziba, Naftali Busakhala, Kara Wools‐Kaloustian, Jeffrey N. Martin	39
12	Estimation of mortality among HIV-infected people on antiretroviral treatment in east Africa: a sampling based approach in an observational, multisite, cohort study 2015 ·The Lancet HIV ·Elvin Geng, Thomas Odeny, Rita Lyamuya, (unknown), Lameck Diero, Mwebesa Bwana, Winnie Muyindike, Paula Braitstein, (unknown), Andrew Kambugu, Elizabeth A. Bukusi, Megan Wenger, Kara Wools‐Kaloustian, David V. Glidden, Constantin T. Yiannoutsos, Jeffrey N. Martin	70
13	Empiric Deworming and CD4 Count Recovery in HIV-Infected Ugandans Initiating Antiretroviral Therapy 2014 ·PLoS neglected tropical diseases ·Alexander Lankowski, Alexander C. Tsai, (unknown), Mwebesa Bwana, Jessica E. Haberer, Megan Wenger, Jeffrey N. Martin, David R. Bangsberg, Peter W. Hunt, Mark J. Siedner	9
14	Diagnosing Kaposi’s Sarcoma (KS) in East Africa: how accurate are clinicians and pathologists? 2012 ·Infectious Agents and Cancer ·Erin Amerson, Nathan Buziba, Henry Wabinga, Megan Wenger, Mwebesa Bwana, Winnie Muyindike, (unknown), (unknown), Edward Mbidde, Constantin T. Yiannoutsos, Kara Wools‐Kaloustian, Beverly Musick, Philip E. LeBoit, (unknown), Beth S. Ruben, Paul A. Volberding, Toby Maurer, Jeffrey N. Martin	11
15	Prospective evaluation of the impact of potent antiretroviral therapy on the incidence of Kaposi’s Sarcoma in East Africa: findings from the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Consortium 2012 ·Infectious Agents and Cancer ·Jeffrey N. Martin, Megan Wenger, (unknown), Nathan Buziba, Mwebesa Bwana, Winnie Muyindike, (unknown), Erin Amerson, Constantin T. Yiannoutsos, Beverly Musick, Philip E. LeBoit, Timothy H. McCalmont, Beth S. Ruben, Toby Maurer, Kara Wools‐Kaloustian	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact